Next generation eCOA/ePRO technology that is powering real world studies
Our modern patient engagement platform is flexible to meet the needs of any real world evidence research, from early access programmes to academic studies
Our unparralelled patient engagement capabilities accelerate real world data capture, transforming the quality and accuracy of results in real world studies across the globe.
At uMotif, we understand that success in real world evidence studies lies in the ability to adapt to diverse study types, settings, and goals.
Our flexible and configurable technology empowers sponsors, CROs, and partners to engage patients, fostering retention and participation in real world resarch.
From label extensions to novel claims, our platform amplifies the impact of real world evidence data, providing fresh insights into diseases and patient outcomes.
With a track record of enabling fully virtual studies with thousands of participants, as well as pivotal late-phase trials, uMotif ensures that the technology seamlessly aligns with the realities of modern real world research.
Real World Insights
Insights from our real-world patient engagement experts
-
Hear from the patients behind the research: Mich’s story
Mick shares how using the app as part of the 100 for Parkinson’s study has made him feel more positive about his condition and is now using it in the real world to help him and his healthcare providers manage his disease
Watch video -
Case Study: Chronic Pain | Cloudy With a Chance of Pain
uMotif eCOA/ePRO platform helps researchers decode connection between pain and weather.
Read case study -
Blog: Using patient experience data in real world studies
Patient insights are expected to become increasingly instrumental in optimising medicine development and regulatory decision making.
Read blog
“We needed an easy-to-use solution, that can be used across multiple countries, to manage a high volume of data capture – uMotif’s platform provides the opportunity to engage our patients”
Professor Pratik Choudhary Project Lead, King’s College London